Our data indicate that glial cell-derived factors induce the transcriptional and translational process of EMT in tumor cells, and we confirmed this by measurement of key markers of this process such as downregulation of E-cadherin, as well as upregulation of N-cadherin and vimentin. The gene discussed is CDH2; the disease is neoplasm.